ResMed (RMD) CEO Farrell gave up 7,896.57 shares at $250.10 to cover taxes or an exercise price
Insider transactions reported
Michael J. Farrell (Chairman and CEO at ResMed Inc., RMD) reported that they gave up 7,896.57 shares at $250.10 to cover taxes or an exercise price on Nov 11, 2025. After these transactions the filing shows 459,969 shares held directly.
- Reporting person
- Farrell Michael J.
- Role
- Chairman and CEO
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 11, 2025 | Shares withheld for taxes or exercise price (F) | ResMed Common Stock1, 2, 3 | -7,896.567 | avg $250.10 | $1.97M | 459,969 direct |
Holdings before and after
- ResMed Common Stock: 467,865.545 to 459,969 direct
Other positions listed
- ResMed Common Stock: 2,090 indirect, Lisette and Michael Farrell Family Trust
Footnotes from the filing
- 1. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Farrell report in this RMD Form 4?
Michael J. Farrell (Chairman and CEO at ResMed Inc., RMD) reported that they gave up 7,896.57 shares at $250.10 to cover taxes or an exercise price on Nov 11, 2025. After these transactions the filing shows 459,969 shares held directly.
How many RMD shares does Farrell hold after this filing?
The filing shows 459,969 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for RMD
Earlier insider filings at RMD
- Nov 13, 2025Director De Witte Jan sold $121,872 worth of ReMed Common Stock (487 units at $250.25) and covered exercise/tax liability with 76 units of ReMed Common Stock, decreasing direct ownership by 10% to 5,242 units (SEC Form 4)
- Nov 13, 2025Global General Counsel Rider Michael J covered exercise/tax liability with 1,525 units of ResMed Common Stock, decreasing direct ownership by 13% to 9,841 units (SEC Form 4)
- Nov 11, 2025Chairman and CEO Farrell Michael J. exercised 8,011 units of ResMed Common Stock at a strike of $101.64 and sold $2,000,773 worth of ResMed Common Stock (8,011 units at $249.75) (SEC Form 4)
- Nov 4, 2025Chief Financial Officer Sandercock Brett exercised 2,000 units of ResMed Common Stock at a strike of $101.64 and sold $742,620 worth of ResMed Common Stock (3,000 units at $247.54), decreasing direct ownership by 1% to 85,745 units (SEC Form 4)
- Oct 9, 2025Chief Executive Officer Farrell Michael J. exercised 8,009 units of ResMed Common Stock at a strike of $101.64 and sold $2,265,332 worth of ResMed Common Stock (8,009 units at $282.85) (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Follow RMD and get a push notification the moment its next story breaks.